Iovance Biotherapeutics, Inc. · NASDAQ:IOVA

Puri Raj K. exercised options for 9,766 Iovance Biotherapeutics, Inc. shares (Form 4)

Traded Sep 8, 2026 · Filed Sep 10, 2026

On Sep 8, 2026, Puri Raj K. (Chief Regulatory Officer) exercised options for 9,766 Iovance Biotherapeutics, Inc. shares, leaving 256,364 shares. Filed Sep 10, 2026 (Form 4).

Options exercised
9,766 shares
Holding after
256,364 shares
Trading plan
No
Role
Chief Regulatory Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 8, 2026Common StockOption exercise9,766260,842Direct
Sep 8, 2026Common StockShares withheld for tax4,478US$8.70256,364Direct

Source

View original at SEC

Related